Drug monitoring in systemic lupus erythematosus.

Therapeutic drug monitoring (TDM) is not yet accepted by systemic lupus erythematosus (SLE) treatment guidelines. Studies in SLE, however, have proven benefit in three areas: identification of non-adherence or poor adherence; targets for clinical benefit; and ranges of toxicity. This review covers the data on three medications commonly used for SLE, drawing on studies from both the SLE and non-SLE literature. Copyright © 2022 Elsevier Ltd. All rights reserved.

Citation

Michelle Petri. Drug monitoring in systemic lupus erythematosus. Current opinion in pharmacology. 2022 Jun;64:102225

Mesh Tags

Substances

PMID: 35490454

search → result